Agudera, Queen Zyra A.

HRN: 19-98-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
CEFTRIAXONE 1G (VIAL)
12/03/2022
12/09/2022
IVDRIP
1g
Once A Day
Pediatric Community Acquired Pneumonia-C; T/c Uti
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: